Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Gynecol Oncol. 2020 Jan 15;156(3):647–653. doi: 10.1016/j.ygyno.2019.12.037

Table 2:

Medical history of DICER1-carrier women with Ovarian Sertoli Leydig cell tumors

Patient Age at Menarche (yrs) Age at Tumor (yrs) Surgical Treatment Pathology Report Chemotherapy
1: 114–1 13 8 1st: Left oophorectomy, omentectomy Sertoli-Leydig cell tumor, retiform variant No
14 2nd: Right salpingo-oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation No
2: 151–1 14 13 Left salpingo-oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation Yes
3: 145–4 11 14 1st: Right salpingo-oophorectomy Unavailable, but mother said tumor had hair and teeth, suggesting dermoid cyst No
60 2nd: Left salpingo-oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation Yes
4: 151–2 16 16 Left salpingo-oophorectomy Unavailable, but menses resumed after oophorectomy No
5: 135–1 11 16 Right salpingo-oophorectomy Gynandroblastoma No
6: 135–2 11 16 Right salpingo-oophorectomy Gynandroblastoma Yes
7: 168–1 13 17 Right oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation No
8: 141–1 14 18 Right salpingo-oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation No
9: 133–1 12 40 1st: Left salpingo-oophorectomy Sertoli-Leydig cell tumor of intermediate differentiation No
40 2nd: Second surgery 3 months later; laparoscopic hysterectomy, Right salpingo-oophorectomy Carcinoid tumor No